<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35563430</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1422-0067</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>23</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular sciences</Title>
          <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cytopathological Outcomes of Knocking down Expression of Mitochondrial Complex II Subunits in <i>Dictyostelium discoideum</i>.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">5039</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23095039</ELocationID>
        <Abstract>
          <AbstractText>Mitochondrial Complex II is composed of four core subunits and mutations to any of the subunits result in lowered Complex II activity. Surprisingly, although mutations in any of the subunits can yield similar clinical outcomes, there are distinct differences in the patterns of clinical disease most commonly associated with mutations in different subunits. Thus, mutations to the SdhA subunit most often result in mitochondrial disease phenotypes, whilst mutations to the other subunits SdhB-D more commonly result in tumour formation. The reason the clinical outcomes are so different is unknown. Here, we individually antisense-inhibited three of the Complex II subunits, SdhA, SdhB or SdhC, in the simple model organism <i>Dictyostelium discoideum</i>. Whilst SdhB and SdhC knockdown resulted in growth defects on bacterial lawns, antisense inhibition of SdhA expression resulted in a different pattern of phenotypic defects, including impairments of growth in liquid medium, enhanced intracellular proliferation of the bacterial pathogen <i>Legionella pneumophila</i> and phagocytosis. Knockdown of the individual subunits also produced different abnormalities in mitochondrial function with only SdhA knockdown resulting in broad mitochondrial dysfunction. Furthermore, these defects were shown to be mediated by the chronic activation of the cellular energy sensor AMP-activated protein kinase. Our results are in agreement with a role for loss of function of SdhA but not the other Complex II subunits in impairing mitochondrial oxidative phosphorylation and they suggest a role for AMP-activated protein kinase in mediating the cytopathological outcomes.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lay</LastName>
            <ForeName>Sui</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0003-1155-0684</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Physiology, Anatomy and Microbiology, La Trobe University, Bundoora, VIC 3086, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pearce</LastName>
            <ForeName>Xavier</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physiology, Anatomy and Microbiology, La Trobe University, Bundoora, VIC 3086, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sanislav</LastName>
            <ForeName>Oana</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physiology, Anatomy and Microbiology, La Trobe University, Bundoora, VIC 3086, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fisher</LastName>
            <ForeName>Paul Robert</ForeName>
            <Initials>PR</Initials>
            <Identifier Source="ORCID">0000-0003-1884-6306</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Physiology, Anatomy and Microbiology, La Trobe University, Bundoora, VIC 3086, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Annesley</LastName>
            <ForeName>Sarah Jane</ForeName>
            <Initials>SJ</Initials>
            <Identifier Source="ORCID">0000-0002-7604-3985</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Physiology, Anatomy and Microbiology, La Trobe University, Bundoora, VIC 3086, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Sci</MedlineTA>
        <NlmUniqueID>101092791</NlmUniqueID>
        <ISSNLinking>1422-0067</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 1.3.5.1</RegistryNumber>
          <NameOfSubstance UI="D042963">Electron Transport Complex II</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.31</RegistryNumber>
          <NameOfSubstance UI="D055372">AMP-Activated Protein Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D055372" MajorTopicYN="N">AMP-Activated Protein Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004023" MajorTopicYN="Y">Dictyostelium</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D042963" MajorTopicYN="N">Electron Transport Complex II</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D028361" MajorTopicYN="Y">Mitochondrial Diseases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Complex II</Keyword>
        <Keyword MajorTopicYN="N">Dictyostelium discoideum</Keyword>
        <Keyword MajorTopicYN="N">mitochondria</Keyword>
        <Keyword MajorTopicYN="N">succinate dehydrogenase</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>1</Hour>
          <Minute>5</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35563430</ArticleId>
        <ArticleId IdType="pmc">PMC9105181</ArticleId>
        <ArticleId IdType="doi">10.3390/ijms23095039</ArticleId>
        <ArticleId IdType="pii">ijms23095039</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Farshbaf M., Kiani-Esfahani A. Succinate dehydrogenase: Prospect for neurodegenerative diseases. Mitochondrion. 2018;42:77–83. doi: 10.1016/j.mito.2017.12.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mito.2017.12.002</ArticleId>
            <ArticleId IdType="pubmed">29225013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Vranken J.G., Na U., Winge D.R., Rutter J. Protein-mediated assembly of succinate dehydrogenase and its cofactors. Crit. Rev. Biochem. Mol. Biol. 2015;50:168–180. doi: 10.3109/10409238.2014.990556.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/10409238.2014.990556</ArticleId>
            <ArticleId IdType="pmc">PMC4653115</ArticleId>
            <ArticleId IdType="pubmed">25488574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma P., Maklashina E., Cecchini G., Iverson T.M. Maturation of the respiratory complex II flavoprotein. Curr. Opin. Struct. Biol. 2019;59:38–46. doi: 10.1016/j.sbi.2019.01.027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.sbi.2019.01.027</ArticleId>
            <ArticleId IdType="pmc">PMC6731172</ArticleId>
            <ArticleId IdType="pubmed">30851631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fullerton M., McFarland R., Taylor R.W., Alston C.L. The genetic basis of isolated mitochondrial complex II deficiency. Mol. Genet. Metab. 2020;131:53–65. doi: 10.1016/j.ymgme.2020.09.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ymgme.2020.09.009</ArticleId>
            <ArticleId IdType="pmc">PMC7758838</ArticleId>
            <ArticleId IdType="pubmed">33162331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parfait B., Chretien D., Rotig A., Marsac C., Munnich A., Rustin P. Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome. Hum. Genet. 2000;106:236–243. doi: 10.1007/s004399900218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s004399900218</ArticleId>
            <ArticleId IdType="pubmed">10746566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birch-Machin M., Taylor R.W., Cochran B., Ackrell B.A.C., Turnbull D.M. Late-Onset Optic Atrophy, Ataxia, andMyopathy Associated with a Mutation of aComplex II Gene. Ann. Neurol. 2000;48:330–335. doi: 10.1002/1531-8249(200009)48:3&lt;330::AID-ANA7&gt;3.0.CO;2-A.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1531-8249(200009)48:3&lt;330::AID-ANA7&gt;3.0.CO;2-A</ArticleId>
            <ArticleId IdType="pubmed">10976639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Renkema G.H., Wortmann S.B., Smeets R.J., Venselaar H., Antoine M., Visser G., Ben-Omran T., van den Heuvel L.P., Timmers H.J., Smeitink J.A., et al.  SDHA mutations causing a multisystem mitochondrial disease: Novel mutations and genetic overlap with hereditary tumors. Eur. J. Hum. Genet. 2015;23:202–209. doi: 10.1038/ejhg.2014.80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ejhg.2014.80</ArticleId>
            <ArticleId IdType="pmc">PMC4297908</ArticleId>
            <ArticleId IdType="pubmed">24781757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao T., Mu X., You Q. Succinate: An initiator in tumorigenesis and progression. Oncotarget. 2017;8:53819–53828. doi: 10.18632/oncotarget.17734.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.17734</ArticleId>
            <ArticleId IdType="pmc">PMC5581152</ArticleId>
            <ArticleId IdType="pubmed">28881853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yankovskaya V., Horsefield R., Tornroth S., Luna-Chavez C., Miyoshi H., Leger C., Byrne B., Cecchini G., Iwata S. Architecture of succinate dehydrogenase and reactive oxygen species generation. Science. 2003;299:700–704. doi: 10.1126/science.1079605.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1079605</ArticleId>
            <ArticleId IdType="pubmed">12560550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saskői É., Nyírő G., Likó I., Mátyási B., Petővári G., Mészáros K., Kovács A.L., Patthy L., Supekar S., Fan H. The SDHB Arg230His mutation causing familial paraganglioma alters glycolysis in a new Caenorhabditis elegans model. Dis. Model. Mech. 2020;13:dmm044925. doi: 10.1242/dmm.044925.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dmm.044925</ArticleId>
            <ArticleId IdType="pmc">PMC7578352</ArticleId>
            <ArticleId IdType="pubmed">32859697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takács-Vellai K., Farkas Z., Ősz F., Stewart G.W. Model systems in SDHx-related pheochromocytoma/paraganglioma. Cancer Metastasis Rev. 2021;40:1177–1201. doi: 10.1007/s10555-021-10009-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10555-021-10009-z</ArticleId>
            <ArticleId IdType="pmc">PMC8825606</ArticleId>
            <ArticleId IdType="pubmed">34957538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baldauf S.L., Doolittle W.F. Origin and evolution of the slime molds (Mycetozoa) Proc. Natl. Acad. Sci. USA. 1997;94:12007–12012. doi: 10.1073/pnas.94.22.12007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.94.22.12007</ArticleId>
            <ArticleId IdType="pmc">PMC23686</ArticleId>
            <ArticleId IdType="pubmed">9342353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eichinger L., Pachebat J.A., Glockner G., Rajandream M.A., Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q., et al.  The genome of the social amoeba Dictyostelium discoideum. Nature. 2005;435:43–57. doi: 10.1038/nature03481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature03481</ArticleId>
            <ArticleId IdType="pmc">PMC1352341</ArticleId>
            <ArticleId IdType="pubmed">15875012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogawa S., Yoshino R., Angata K., Iwamoto M., Pi M., Kuroe K., Matsuo K., Morio T., Urushihara H., Yanagisawa K., et al.  The mitochondrial DNA of Dictyostelium discoideum: Complete sequence, gene content and genome organization. Mol. Gen. Genet. 2000;263:514–519. doi: 10.1007/PL00008685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/PL00008685</ArticleId>
            <ArticleId IdType="pubmed">10821186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Annesley S.J., Fisher P.R. Dictyostelium discoideum—A model for many reasons. Mol. Cell. Biochem. 2009;329:73–91. doi: 10.1007/s11010-009-0111-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11010-009-0111-8</ArticleId>
            <ArticleId IdType="pubmed">19387798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Annesley S.J., Chen S., Francione L.M., Sanislav O., Chavan A.J., Farah C., De Piazza S.W., Storey C.L., Ilievska J., Fernando S.G., et al.  Dictyostelium, a microbial model for brain disease. BBA-Gen. Subj. 2014;1840:20. doi: 10.1016/j.bbagen.2013.10.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbagen.2013.10.019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bokko P.B., Francione L., Bandala-Sanchez E., Ahmed A.U., Annesley S.J., Huang X., Khurana T., Kimmel A.R., Fisher P.R. Diverse cytopathologies in mitochondrial disease are caused by AMP-activated protein kinase signaling. Mol. Biol. Cell. 2007;18:1874–1886. doi: 10.1091/mbc.e06-09-0881.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1091/mbc.e06-09-0881</ArticleId>
            <ArticleId IdType="pmc">PMC1855013</ArticleId>
            <ArticleId IdType="pubmed">17332500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie D.G., Carling D., Gamblin S.J. AMP-activated protein kinase: Also regulated by ADP? Trends Biochem. Sci. 2011;36:470–477. doi: 10.1016/j.tibs.2011.06.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tibs.2011.06.004</ArticleId>
            <ArticleId IdType="pubmed">21782450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Momcilovic M., Hong S.P., Carlson M. Mammalian TAK1 activates SNF1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J. Biol. Chem. 2006;281:25336–25343. doi: 10.1074/jbc.M604399200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M604399200</ArticleId>
            <ArticleId IdType="pubmed">16835226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawley S.A., Pan D.A., Mustard K.J., Ross L., Bain J., Edelman A.M., Frenguelli B.G., Hardie D.G. Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005;2:9–19. doi: 10.1016/j.cmet.2005.05.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2005.05.009</ArticleId>
            <ArticleId IdType="pubmed">16054095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Francione L.M., Fisher P.R. Heteroplasmic mitochondrial disease in Dictyostelium discoideum. Biochem. Pharmacol. 2011;82:1510–1520. doi: 10.1016/j.bcp.2011.07.071.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bcp.2011.07.071</ArticleId>
            <ArticleId IdType="pubmed">21787754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Francione L., Smith P.K., Accari S.L., Taylor P.E., Bokko P.B., Bozzaro S., Beech P.L., Fisher P.R. Legionella pneumophila multiplication is enhanced by chronic AMPK signalling in mitochondrially diseased Dictyostelium cells. Dis. Models Mech. 2009;2:479–489. doi: 10.1242/dmm.003319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dmm.003319</ArticleId>
            <ArticleId IdType="pubmed">19638422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morita M., Gravel S.P., Hulea L., Larsson O., Pollak M., St-Pierre J., Topisirovic I. mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle. 2015;14:473–480. doi: 10.4161/15384101.2014.991572.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/15384101.2014.991572</ArticleId>
            <ArticleId IdType="pmc">PMC4615141</ArticleId>
            <ArticleId IdType="pubmed">25590164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maklashina E., Rajagukguk S., Iverson T.M., Cecchini G. The unassembled flavoprotein subunits of human and bacterial complex II have impaired catalytic activity and generate only minor amounts of ROS. J. Biol. Chem. 2018;293:7754–7765. doi: 10.1074/jbc.RA118.001977.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.RA118.001977</ArticleId>
            <ArticleId IdType="pmc">PMC5961047</ArticleId>
            <ArticleId IdType="pubmed">29610278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson L., Pollard A.E., Penfold L., Muckett P.J., Whilding C., Bohlooly Y.M., Wilson P., Carling D. Chronic activation of AMP-activated protein kinase leads to early-onset polycystic kidney phenotype. Clin. Sci. 2021;135:2393–2408. doi: 10.1042/CS20210821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/CS20210821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thornton C., Bright N.J., Sastre M., Muckett P.J., Carling D. AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid beta-peptide exposure. Biochem. J. 2011;434:503–512. doi: 10.1042/BJ20101485.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BJ20101485</ArticleId>
            <ArticleId IdType="pubmed">21204788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dyck J.R., Lopaschuk G.D. AMPK alterations in cardiac physiology and pathology: Enemy or ally? J. Physiol. 2006;574:95–112. doi: 10.1113/jphysiol.2006.109389.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/jphysiol.2006.109389</ArticleId>
            <ArticleId IdType="pmc">PMC1817803</ArticleId>
            <ArticleId IdType="pubmed">16690706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reznick R.M., Zong H., Li J., Morino K., Moore I.K., Yu H.J., Liu Z.X., Dong J., Mustard K.J., Hawley S.A., et al.  Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab. 2007;5:151–156. doi: 10.1016/j.cmet.2007.01.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2007.01.008</ArticleId>
            <ArticleId IdType="pmc">PMC1885964</ArticleId>
            <ArticleId IdType="pubmed">17276357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen S., Annesley S.J., Jasim R.A.F., Fisher P.R. The Parkinson’s Disease-Associated Protein DJ-1 Protects Dictyostelium Cells from AMPK-Dependent Outcomes of Oxidative Stress. Cells. 2021;10:1874.  doi: 10.3390/cells10081874.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cells10081874</ArticleId>
            <ArticleId IdType="pmc">PMC8392454</ArticleId>
            <ArticleId IdType="pubmed">34440642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suski J.M., Lebiedzinska M., Bonora M., Pinton P., Duszynski J., Wieckowski M.R. Relation between mitochondrial membrane potential and ROS formation. Methods Mol. Biol. 2012;810:183–205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22057568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hadrava Vanova K., Kraus M., Neuzil J., Rohlena J. Mitochondrial complex II and reactive oxygen species in disease and therapy. Redox Rep. 2020;25:26–32. doi: 10.1080/13510002.2020.1752002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/13510002.2020.1752002</ArticleId>
            <ArticleId IdType="pmc">PMC7178880</ArticleId>
            <ArticleId IdType="pubmed">32290794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rustin P., Munnich A., Rotig A. Succinate dehydrogenase and human diseases: New insights into a well-known enzyme. Eur. J. Hum. Genet. 2002;10:289–291. doi: 10.1038/sj.ejhg.5200793.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.ejhg.5200793</ArticleId>
            <ArticleId IdType="pubmed">12082502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bezawork-Geleta A., Wen H., Dong L., Yan B., Vider J., Boukalova S., Krobova L., Vanova K., Zobalova R., Sobol M., et al.  Alternative assembly of respiratory complex II connects energy stress to metabolic checkpoints. Nat. Commun. 2018;9:2221. doi: 10.1038/s41467-018-04603-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-018-04603-z</ArticleId>
            <ArticleId IdType="pmc">PMC5992162</ArticleId>
            <ArticleId IdType="pubmed">29880867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mroczek K., Fernando S., Fisher P.R., Annesley S.J. Interactions and Cytotoxicity of Human Neurodegeneration- Associated Proteins Tau and α-Synuclein in the Simple Model Dictyostelium discoideum. Front. Cell Dev. Biol. 2021;9:2502. doi: 10.3389/fcell.2021.741662.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcell.2021.741662</ArticleId>
            <ArticleId IdType="pmc">PMC8450459</ArticleId>
            <ArticleId IdType="pubmed">34552934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nellen W., Silan C., Firtel R. DNA-Mediated Transformation in Dictyostelium discoideum:Regulated Expression of an Actin Gene Fusion. Mol. Cell. Biol. 1984;4:2890–2898.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC369302</ArticleId>
            <ArticleId IdType="pubmed">6098825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilczynska Z., Fisher P.R. Analysis of a complex plasmid insertion in a phototaxis-deficient transformant of Dictyostelium discoideum selected on a Micrococcus luteus lawn. Plasmid. 1994;32:182–194. doi: 10.1006/plas.1994.1054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/plas.1994.1054</ArticleId>
            <ArticleId IdType="pubmed">7846143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith P.K., Sen M.G., Fisher P.R., Annesley S.J. Modelling of Neuronal Ceroid Lipofuscinosis Type 2 in Dictyostelium discoideum Suggests That Cytopathological Outcomes Result from Altered TOR Signalling. Cells. 2019;8:469.  doi: 10.3390/cells8050469.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cells8050469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barrientos A., Fontanesi F., Diaz F. Evaluation of the mitochondrial respiratory chain and oxidative phosphorylation system using polarography and spectrophotometric enzyme assays. Curr. Protoc. Hum. Genet. 2009;63:19.3.1–19.3.14. doi: 10.1002/0471142905.hg1903s63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/0471142905.hg1903s63</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maselli A., Laevsky G., Knecht D.A. Kinetics of binding, uptake and degradation of live fluorescent (DsRed) bacteria by Dictyostelium discoideum. Microbiology. 2002;148:413–420. doi: 10.1099/00221287-148-2-413.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/00221287-148-2-413</ArticleId>
            <ArticleId IdType="pubmed">11832505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Annesley S.J., Fisher P.R.  Chemotaxis. Volume 571 Humana Press; Totowa, NJ, USA: 2009. Dictyostelium slug phototaxis. Methods in Molecular Biology.</Citation>
        </Reference>
        <Reference>
          <Citation>Lay S., Sanislav O., Annesley S.J., Fisher P.R.  Chemotaxis. Volume 1407 Humana Press; New York, NY, USA: 2016. Mitochondrial Stress Tests Using Seahorse Respirometry on Intact Dictyostelium discoideum Cells. Methods in Molecular Biology.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
